SMSara J. Meltzer

Sara J. Meltzer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sara J. Meltzer has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lowering the Diagnostic Threshold for Gestational Diabetes: A Comparison of 2 Centres

    by Sanaz Azizi, Agnieszka Majdan, Rachel Bond, Natasha Garfield, Sara Meltzer, Shaun Eintracht, Kathryn Morrison, Julia Ma, Kaberi Dasgupta, Tricia Peters

  • Open Access

    Trends in National Canadian Guideline Recommendations for the Screening and Diagnosis of Gestational Diabetes Mellitus over the Years: A Scoping Review

    by Joseph Mussa, Sara Meltzer, Rachel Bond, Natasha Garfield, Kaberi Dasgupta

    Canada’s largest national obstetric and diabetology organizations have recommended various algorithms for the screening of gestational diabetes mellitus (GDM) over the years. Though uniformity across recommendations from clinical practice guidelines (CPGs) is desirable, historically, national guidelines from Diabetes Canada (DC) and the Society of Obstetricians and Gynaecologists of Canada (SOGC) have differed. Lack of consensus has led to variation in screening approaches, rendering precise ascertainment of GDM prevalence challenging. To highlight the reason and level of disparity in Canada, we conducted a scoping review of CPGs released by DC and the SOGC over the last thirty years and distributed a survey on screening practices among Canadian physicians. Earlier CPGs were based on expert opinion, leading to different recommendations from these organizations. However, as a result of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study, disparities between DC and the SOGC no longer exist and many Canadian physicians have adopted their recent recommendations. Given that Canadian guidelines now recommend two different screening programs (one step vs. two step), lack of consensus on a single diagnostic threshold continues to exist, resulting in differing estimates of GDM prevalence. Our scoping review highlights these disparities and provides a step forward towards reaching a consensus on one unified threshold.


  • Open Access

    Health behaviour changes in partners of women with recent gestational diabetes: a phase IIa trial

    by Anne-Sophie Brazeau, Sara J. Meltzer, Romina Pace, Natasha Garfield, Ariane Godbout, Leslie Meissner, Elham Rahme, Deborah Da Costa, Kaberi Dasgupta

    We recently demonstrated that a gestational diabetes history in mothers is associated with higher postpartum incident diabetes not only in mothers but also in fathers. In the present study, we examined changes in health behaviours and cardiometabolic profiles in both mothers and partners who participated in a diabetes prevention program within 5 years of a gestational diabetes pregnancy. Couples were enrolled into a 13-week program that included 5 half-day group sessions and web/telephone-based support between sessions. It was designed in consultation with patients and previously studied in mothers. We computed mean changes from baseline (95% CI) for physical activity, eating, and sleep measures, and cardiometabolic parameters (fasting and 2-h post glucose load plasma glucose, BMI, blood pressure) in both partners and mothers. Among 59 couples enrolled, 45 partners (76%) and 47 mothers (80%) completed final evaluations. Baseline cardiometabolic measures averaged within normal limits. Similar to mothers, partners increased physical activity (+ 1645 steps/day, 95%CI 730, 2561; accelerometer assessed moderate-to-vigorous physical activity + 36.4 min/week, 95% CI 1.4, 71.4) and sleep duration (+ 0.5 h/night, 95% CI 0.1, 0.9) and reduced the sodium-to-potassium ratio of food intake (− 0.09 95% CI -0.19, − 0.001). No conclusive changes were observed in glucose measures or insulin resistance; in analyses combining mothers and partners, systolic blood pressure decreased (− 2.7 mmHg, 95% CI -4.4, − 1.0). Partners and mothers demonstrated improved physical activity, sleep, and dietary quality. Baseline cardiometabolic profiles averaged at normal values and there were no changes in glucose or insulin resistance; some blood pressure impact was observed. While strategies need to be developed to attract participants at higher cardiometabolic risk, this study demonstrates that partners of women within 5 years of a gestational diabetes diagnosis can be recruited and do achieve health behaviour change. ClinicalTrials.gov: NCT02343354 (date of registration: January 22, 2015).


  • Unhealthy lifestyles and gestational diabetes

    by Sara J Meltzer

    Another good reason for young women to quit smoking, eat better, and exercise


  • Open Access

    Group-based activities with on-site childcare and online support improve glucose tolerance in women within 5 years of gestational diabetes pregnancy

    by Anne-Sophie Brazeau, Aaron Leong, Sara J Meltzer, Rani Cruz, Deborah DaCosta, Mary Hendrickson-Nelson, Lawrence Joseph, Kaberi Dasgupta, MoMM study group

    Women with gestational diabetes history are at increased risk for type 2 diabetes. They face specific challenges for behavioural changes, including childcare responsibilities. The aim of this study is to test a tailored type 2 diabetes prevention intervention in women within 5 years of a pregnancy with gestational diabetes, in terms of effects on weight and cardiometabolic risk factors.


  • In-Hospital Diabetes Management

    by Alice Y.Y. Cheng, Robyn L. Houlden, Sara J. Meltzer


  • Open Access

    Prepregnancy Care: A Shared Responsibility

    by Sara J. Meltzer


  • Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one‐step and two‐step methods

    by Sj Meltzer, J Snyder, Jr Penrod, M Nudi, L Morin

    Please cite this paper as: Meltzer S, Snyder J, Penrod J, Nudi M, Morin L. Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one‐step and two‐step methods. BJOG 2010;117:407–415.Objective  To conduct a cost minimisation analysis of three methods of gestational diabetes mellitus (GDM) screening and diagnosis.Design  Prospective randomised controlled trial.Setting  University teaching hospital.Population  Pregnant women (n = 1594) presenting for GDM screening.Methods  Women presenting for GDM screening, who consented to participate, were randomised to GR1 [1‐hour, 50‐g glucose screen (GS) ± 3‐hour, 100‐g oral glucose tolerance test (OGTT)], GR2 (50‐g GS ± 2‐hour, 75‐g OGTT) or GR3 (2‐hour, 75‐g OGTT). Demographics, health and time/travel cost information were assessed for each glucose testing visit.Main outcome measures  Costs (direct and indirect) and prevalence of GDM diagnosis.Results  The direct sampling costs of the glucose tests per woman were as follows: GS, CAN$12.57; 75‐g OGTT, $36.10; 100‐g OGTT, CAN$48.13. Among women in the two‐step method groups diagnosed with GDM, 39% of the GR1 and 61% of the GR2 groups were diagnosed at the first step by GS ≥ 10.3 mmol/l, according to the Canadian Diabetes Association recommendations, contributing to a lower total cost in these groups. The total costs per woman screened were as follows: GR1, CAN$91.61; GR2, CAN$89.03; GR3, CAN$108.38. The GDM prevalence was similar (3.7%, 3.7% and 3.6%, respectively). The higher costs of GR3 were related to more blood draws and the time required for all women to undergo the 2‐hour OGTT.Conclusions  Careful consideration should be given to an internationally recommended method of universal screening for GDM which minimises the burden and cost for individual women and the healthcare system, yet provides diagnostic efficacy. The two‐step method (GS ± OGTT) accomplished this better than the one‐step method (75‐g OGTT).